Table 3.
Year | Patients/lesions (n) | Mean age (years) | Mean initial MTD (cm) | Mean follow-up (months) | Mean LGR (cm/year) | Mean VGR (cm3/year) |
Progression to metastasis, n (%) | Pathologic RCC | |
---|---|---|---|---|---|---|---|---|---|
Fujimoto et al. [10] | 1995 | 6/6 | 59.7 | 2.47 | 24 | 0.47 | 9.7 | 0 (0) | 5/5 |
Bosniak et al. [11] | 1995 | 37/40 | 65.5 | 1.73 | 39 | 0.36 | 5.26 | 0 (0) | 22/26 |
Oda et al. [12] | 2003 | 16/16 | 54a | 2.0a | 25 | 0.54a | — | 0 (0) | 16/16* |
Volpe et al. [7] | 2004 | 29/32 | 71a | 2.48 | 27.9 | 0.1 | 3.8 | 0 (0) | 8/9 |
Wehle et al. [13] | 2004 | 29/29 | 70 | 1.83 | 32 | 0.12 | — | 0 (0) | 3/4 |
Kato et al. [5] | 2004 | 18/18 | 56.5 | 2.0 | 27 | 0.42 | 4.4 | 0 (0) | 18/18* |
Lamb et al. [14] | 2004 | 36/36 | 76.1 | 7.2 | 27.7 | 0.39 | — | 1 (2.8) | 23/24 |
Chawla et al. [15] | 2006 | 49/61 | 71 | 2.97 | 36 | 0.2 | — | 1 (1.6) | 16/21 |
Youssif et al. [16] | 2007 | 35/44 | 71.8 | 2.2 | 47.6 | 0.21 | 2.7 | 2 (5.7) | 6/8 |
Kouba et al. [17] | 2007 | 43/46 | 67 | 2.92 | 32.8 | 0.7 | — | 0 (0) | 12/14 |
Siu et al. [18] | 2007 | 41/47 | 68 | 2.0 | 29 | 0.27 | — | 1 (2.4) | 10/16 |
Fernando et al. [19] | 2007 | 13/13 | 80.4 | 5.01 | 38.38 | 0.17 | 11.97 | 1 (7.7) | 0 |
Matsuzaki et al. [20] | 2007 | 15/15 | 67 | 2.2 | 38 | 0.06 | 0.67 | 0 (0) | 3/3 |
Lee et al. [8] | 2008 | 30/30 | 65.5 | 2.6 | 12.6 | 0.59 | 19.1 | 3 (10.0) | 30/30* |
Beisland et al. [21] | 2009 | 63/65 | 76.3 | 4.3 | 33 | 0.66 | — | 2 (3.2) | 15/18 |
Crispen et al. [22] | 2009 | 154/173 | 69 | 2.45 | 31 | 0.285 | 17.0 | 2 (1.3) | 52/61 |
Rosales et al. [23] | 2010 | 212/223 | 71a | 2.8a | 35a | 0.34a | — | 4 (1.9) | 32/40 |
Hwang et al. [24] | 2010 | 56/58 | 64.3 | 2.1 | 22 | 0.21 | 1.9 | 0 (0) | 10/15 |
Jewett et al. [25] | 2011 | 127/151 | 73 | 2.1 | 28 | 0.13 | — | 1 (0.7) | 37/46 |
Li et al. [4] | 2012 | 32/32 | 52.2 | 2.14 | 46 | 0.8 | — | 0 (0) | 32/32* |
Mehrazin et al. [26] | 2014 | 68/72 | 68.9 | 5.3 | 38.9 | 0.44 | — | 0 (0) | 16/23 |
Brunocilla et al. [27] | 2014 | 62/64 | 75 | 2.0 | 91.5 | 0.4 | 4.6 | 1 (1.6) | 14/16 |
| |||||||||
Total | 1171/1271 | 69.5 | 2.82 | 34.6 | 0.33 | 9.48 | 19 (1.6) | 380/444 | |
This study | 60/61 | 55 | 2.32 | 39.46 | 0.86 | 20.96 | 1 (1.6) | 61/61 |
aMedian.
—: not stated
∗All cases received delayed surgical intervention and were confirmed to be renal cell carcinoma (RCC) pathologically.